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I mprovements in the surgical management of primary and metastatic brain tumors have resulted in greater extent of resection, less postoperative morbidity, and longer overall survival. Consequently, maximal safe resection is the basic tenet of brain tumor surgery. Advanced surgical techniques such as electrophysiological mapping, intraoperative MRI, and fluorescence-guided surgery have been developed to improve safety and extent of tumor resection.
Despite these surgical advances, studies analyzing patterns of failure after brain tumor surgery indicate that residual tumor near the resection cavity is the most common cause of tumor recurrence. 40 For both malignant and lowgrade gliomas, residual tumor burden is a major cause of morbidity and mortality. 44, 46 In instances of tumor located near eloquent cortex, extent of resection is limited by the need to preserve functional elements. However, even in tumors preoperatively deemed suitable for gross-total resection, at least a fraction of tumor is left behind in more than 75% of cases. 37 This reflects the challenge of identifying tumor-infiltrated and noninfiltrated brain during surgery using current techniques. The implications of residual tumor burden are not limited to glioma. Large clinical investigations indicate that local recurrence after brain metastasis resection is the most common cause of treatment failure, with rates as high as 38%-45%. 3, 39 Therefore, technologies that enable assessment of a surgical cavity for residual tumor are needed. Label-free imaging modalities relying on intrinsic properties, such as the optical density or chemical composition of tissue, AbbreviAtioNs CARS = coherent anti-Stokes Raman scattering; CRS = coherent Raman scattering; SRS = stimulated Raman scattering. sUbMitteD October 30, 2015 . ACCePteD December 1, 2015. iNClUDe wheN CitiNg DOI: 10.3171/2015. 12.FOCUS15557. Despite advances in the surgical management of brain tumors, achieving optimal surgical results and identification of tumor remains a challenge. Raman spectroscopy, a laser-based technique that can be used to nondestructively differentiate molecules based on the inelastic scattering of light, is being applied toward improving the accuracy of brain tumor surgery. Here, the authors systematically review the application of Raman spectroscopy for guidance during brain tumor surgery. Raman spectroscopy can differentiate normal brain from necrotic and vital glioma tissue in human specimens based on chemical differences, and has recently been shown to differentiate tumor-infiltrated tissues from noninfiltrated tissues during surgery. Raman spectroscopy also forms the basis for coherent Raman scattering (CRS) microscopy, a technique that amplifies spontaneous Raman signals by 10,000-fold, enabling real-time histological imaging without the need for tissue processing, sectioning, or staining. The authors review the relevant basic and translational studies on CRS microscopy as a means of providing real-time intraoperative guidance. Recent studies have demonstrated how CRS can be used to differentiate tumor-infiltrated tissues from noninfiltrated tissues and that it has excellent agreement with traditional histology. Under simulated operative conditions, CRS has been shown to identify tumor margins that would be undetectable using standard bright-field microscopy. In addition, CRS microscopy has been shown to detect tumor in human surgical specimens with near-perfect agreement to standard H & E microscopy. The authors suggest that as the intraoperative application and instrumentation for Raman spectroscopy and imaging matures, it will become an essential component in the neurosurgical armamentarium for identifying residual tumor and improving the surgical management of brain tumors.
are among the most promising emerging approaches for tumor margin control. Here, we review the development of modalities based on the Raman effect, a phenomenon that occurs when molecular bonds absorb a portion of the energy of an incident photon. We detail the relevant scientific background of Raman-based technologies that are under evaluation as tools to improve the accuracy of brain tumor surgery.
Methods

Data sources
We conducted a systematic review of the English-language literature, starting with a MEDLINE search using the terms Raman and brain tumor or glioma. The search resulted in 91 matches. The complete bibliography of accepted and rejected studies is available by request to the corresponding author.
literature screening and Catalog Construction
Study selection was accomplished through a 2-level screening approach. The first level consisted of the exclusion of all case reports, letters, comments, guidelines, reviews, abstract-only publications, articles not written in the English language, and MRI-based Raman technologies. The second level required that each article included dealt with one of the following: spectral characterization of neoplastic human brain tissue, imaging of primary brain tumor from either mouse models or human patients, identification of morphological features in Raman images, discrimination of normal from neoplastic tissue using Raman technology, or the use of Raman imaging to interrogate a cellular process disrupted in primary brain tumor cells. After second-level screening, a total of 34 articles were included: 25 articles on Raman spectroscopy and 9 on coherent Raman scattering (CRS) microscopy.
spontaneous raman scattering: A brief overview
Photons can be scattered by molecules in 2 ways. Most are scattered elastically, meaning that their frequency and wavelength are preserved after interaction with a molecule. However, a small fraction of photons transfers energy to molecular bonds and is shifted to a new frequency in a process called the Raman effect, a discovery that resulted in the 1930 Nobel Prize in Physics. 42 The difference in frequency of the scattered photon is called the Raman shift. A Raman shift can result in photons of lower frequency/lower energy (i.e., Stokes scattering) and higher frequency/higher energy photons (i.e., anti-Stokes scattering). This effect is very weak and is not usually observed under normal visual conditions. However, using narrowband laser excitation and a sensitive spectrometer, Raman scattering can be measured.
The Raman spectrum of a molecule can be determined by measuring the Raman shifts caused by interaction with each of its constituent chemical bonds. Raman spectral peaks correspond to specific vibrational modes (e.g., stretching, bending, or scissoring) produced by a chemical bond. For example, the H-C= stretching vibrational mode in the H-C=C-bond plays an essential role in Raman spectroscopy of biological tissues due to the high concentration of fatty acids. Raman spectra can therefore be used as a means of chemical identification. The "vibrational fingerprint" of biological tissues reflects its chemical composition of nucleic acids, protein, and lipids, and is the sum of the vibrational spectra of the tissue constituents. This characteristic led to the hypothesis that the chemical differences between tumor and normal tissue may produce sufficiently distinct Raman spectra to allow accurate brain tumor identification and improve surgical results.
Application of raman spectroscopy in brain tissue
Early reports using Raman spectroscopy for brain imaging were limited to analyzing spontaneous Raman spectra to detect relative differences in the concentration of common molecules. In 1990, Tashibu was able to detect relative levels of water concentration in a normal versus edematous rat brain within a spectral region of 2800-3800 cm -1 . 48 This was possible because of a strong intensity peak at 3390 cm -1 , corresponding to the O-H stretching vibrational mode of water. Use of this early technique was limited beyond this spectral range because of background interference and low sensitivity. Mizuno et al. improved on this technique by using near-infrared Fourier transform Raman spectroscopy to evaluate low-and high-grade glioma, vestibular schwannoma, and central neurocytoma, but found that tumor specimens were spectrally indistinguishable from gray matter. 36 Later studies focused on distinguishing vital tumor from necrotic tissue in glioblastoma biopsy samples for real-time intraoperative brain biopsy guidance. 23, 25, 29 A summary of the major Raman spectroscopy studies can be found in Table 1 . Necrotic specimens have high levels of cholesterol and are easily distinguished from vital tumor tissue, with an accuracy approaching 100%. Other reports were able to further differentiate vital tumor from the invasive tumor margin and edematous white matter. 2, 30, 32 Kalkanis and colleagues developed an imaging technique based on pseudocolor 300-μm and 25-μm square measurement grids mapped onto frozen brain tissue specimens. 23 Red (1004 cm -1 channel), green (1300:1344 cm -1 channel), and blue (1600 cm -1 channel) were used for the color scheme. Relative intensities of each Raman feature determined the color for each pixel. For example, a pixel with a high concentration of protein would be red on the color scale because of the 1004-cm -1 phenylalanine peak. The single-and multichannel color maps were then used to discriminate white matter, gray matter, and tumor tissue. The diagnostic accuracy was approximately 90% using this simple multichannel imaging technique.
While the aforementioned studies used ex vivo specimens from animal models or human brain tumor specimens, fiberoptic Raman spectroscopy probes have been developed for intraoperative use. 5, 9, 20, 26 Fiberoptic probes have been previously used to measure Raman spectra in gastrointestinal, bladder, and cervical cancer surgery. 10, 18, 35 Recently, a handheld probe was developed and used in a clinical trial to integrate Raman spectroscopy into the neurosurgical workflow. 9, 20 The handheld probe was placed in direct contact with the brain in the resection Raman spectroscopic imaging for in vivo detection of cerebral brain metastases
Demonstrates the first use of in vivo Raman spectral mapping of the brain surface to aid tumor resection in a mouse model.
Köhler et al., 2009
Characterization of lipid extracts from brain tissue and tumors using Raman spectroscopy and mass spectrometry Demonstrated increased water and decreased lipid content in glioma versus healthy brain tissues in porcine and human samples, confirmed with mass spectroscopy. Krafft et al., 2009 Disease recognition by infrared and Raman spectroscopy Reviewed Raman spectroscopy applications for assessment of numerous tissues and body fluids, as well as classification and supervised learning algorithms commonly used in analysis of Raman spectra.
Koljenović et al., 2005 Tissue characterization using high wave number
Raman spectroscopy
Established that comparatively diagnostic information can be gleaned from high wave number and low wave number portions of the Raman spectrum from brain and bladder cancer samples in vitro. Near infrared Raman spectra of human brain lipids Demonstrated Raman spectral characteristics of 12 major brain lipids. Hyperspectral Raman microscopy Kast et al., 2015 Identification of regions of normal grey matter and white matter from pathologic glioblastoma and necrosis in frozen sections using Raman imaging
Raman spectra acquired grid-wise across a frozen section of brain tumor differentiated gray matter, white matter, tumor, and necrosis through molecular features.
Kast et al., 2014
Raman molecular imaging of brain frozen tissue sections Frozen sections of brain tissue were mapped using grid-wise acquisition of Raman spectra, identifying boundaries of gray and white matter, necrosis, GBM, and infiltrating tumor.
CONTINUED ON PAGE 4 » cavity. Acquisition time was 0.2 seconds for each area of interest measuring 0.5 mm in diameter. Image analysis indicated that 95% of the Raman spectra were generated by the first 1 mm of tissue below the surface. By analyzing differences in spectral peaks, the investigators were able to distinguish normal brain from tumor-invaded brain (> 15% tumor cell invasion) with an accuracy of 92%, sensitivity of 93%, and specificity of 91%. The Raman spectra of normal brain and tumor cell-infiltrated brain can be seen in Fig. 1 . Accuracy did not significantly differ be-tween low-and high-grade gliomas. These results provide a promising step toward translating Raman spectroscopy to real-time intraoperative use.
brain imaging with Crs Microscopy
The main limitation of spontaneous Raman spectroscopy is that the fraction of inelastically scattered photons is quite small. This results in long image acquisition times, increased image artifact, and poor resolution. To improve this technique, CRS was developed to increase Demonstrated that Raman microspectroscopy can discriminate between healthy and tumoral brain tissue and yield spectroscopic markers associated with the proliferative and invasive properties of glioblastoma ex vivo.
Krafft et al., 2005
Near infrared Raman spectroscopic mapping of native brain tissue and intracranial tumors Initial exploration of Raman spectroscopic mapping of frozen samples of brain tissue, meninges, and brain tumor, demonstrating measurable spectroscopic and structural differences. signal intensity (Table 2) . Two major forms of CRS microscopy have been developed and used in biomedical imaging-coherent anti-Stokes Raman scattering (CARS) and stimulated Raman scattering (SRS). 11, 13 CRS increases signal intensity by using a second excitation beam to coherently drive the vibrational frequency of Raman active chemical bonds. Because CRS produces a signal that is orders of magnitude greater (> 10,000-fold) than spontaneous Raman scattering, CRS microscopy is possible with submicron resolution and up to video-rate imaging speeds. 12, 43 Moreover, standard light microscopy requires thin sectioning to allow light within the visible spectrum to pass through the specimen. CRS microscopy avoids the necessity of thin-slicing because the nonlinear excitation of biological molecules provides intrinsic 3D sectioning. 13 Evans and colleagues used CARS microscopy to image ex vivo samples of an orthotopic human astrocytoma mouse model. 11, 12 Images were obtained in 700 × 700-μm fields of view to produce a high-resolution mosaic image of the entire mouse brain in coronal sections. The histoarchitecture produced by CARS microscopy was confirmed by subsequently staining the same region with standard H & E stain. Imaging depth ranged from 25 to 80 μm, depending on tissue type and wavelength. CARS microscopy was capable of generating chemically selective images of lipid (2845 cm -1 , CH2 symmetric stretching) and proteins (CH3 stretch, 2920 cm -1 ; amide I vibration, 2960 cm -1 ) within samples. Focusing on different peaks of the Raman spectra easily differentiated lipid-rich myelin or protein-rich neuronal cell bodies. A related broadband CARS technique has been developed that uses greater spectral breadth within the fingerprint region of the Raman spectra without compromising imaging speed or sensitivity. 8 The biologically relevant Raman window (500-3500 cm -1 ) was used to image a xenograft glioblastoma mouse model. Pseudocolor broadband CARS microscopy was able to distinguish white matter, gray matter, and tumor, and provide nuclear resolution. SRS has several advantages over CARS, including superior nuclear contrast, a linear relationship between signal intensity and chemical concentration, and a nondistorted spectrum nearly identical to spontaneous Raman allowing for quantitative chemical imaging. In 2008, Freudiger and colleagues published a landmark paper on stimulated Raman scattering microscopy for label-free biomedical imaging. 13 Previous methods achieved a large Raman signal with a photodiode array in combination with a femtosecond amplified laser system. 41 The clinical applicability was halted due to laser-induced tissue damage. 15 Freudiger et al. overcame this difficulty by implementation of a high-sensitivity detection scheme based on lock-in detection such that lower peak power, high-repetition rate Broadband CARS microscopy was used to image the entire biologically relevant Raman window (500-3500 cm −1 ), including the weak "fingerprint" region to increase sensitivity.
Galli et al., 2014
Effects of tissue fixation on coherent anti-Stokes Raman scattering images of brain Formalin fixation does not significantly degrade chemical contrast in CARS imaging, though methanol-acetone fixation is incompatible with subsequent CARS microscopy due to alterations in lipid content.
Uckermann et al., 2014
Label-free delineation of brain tumors by coherent anti-Stokes Raman scattering microscopy in an orthotopic mouse model and human glioblastoma CARS imaging of the C-H vibrational mode enabled cellular-resolution identification of tumor cells in frozen sections of orthotopic mouse models of GBM and brain metastases (melanoma, breast cancer).
Evans et al., 2007 Chemically-selective imaging of brain structures with CARS microscopy
Demonstrated the use of CARS microscopy to identify normal brain structures and primary glioma in fresh unfixed and unstained ex vivo brain tissue. SRS microscopy Hu et al., 2015 Vibrational imaging of glucose uptake activity in live cells and tissues by stimulated Raman scattering lasers could be used. The high sensitivity for lipid detection by SRS is well suited for imaging the central nervous system due to the high concentration of lipid-rich myelin. For example, focusing on the 2845 cm -1 shift is ideal for visualizing axon bundles in the corpus callosum due to the high lipid content of myelin sheaths. To make in vivo imaging possible, a novel microscope configuration was designed to allow for approximately 30% of the backscattered light to reach the objective, 3 times more than standard microscopy. 43 This advance increased the imaging speed by 3 orders of magnitude to video-rate, eliminating motion artifact.
Ji and colleagues described the use of rapid, label-free SRS microscopy for in vivo imaging of brain tumors. 22 A comparison of SRS microscopy versus traditional brightfield microscopy of high-and low-grade glioma can be found in Fig. 2 . Video-rate SRS microscopy in combination with a human infiltrative glioblastoma xenograft mouse model was used. A "cranial window" model with clear coverslip allowed for direct visualization of the cortical surface that included normal brain and tumor invasion. 38 Normal and tumor-infiltrated brain at the cortical surface were easily identified on SRS microscopy that were not visible on standard bright-field microscopy. The brain/tumor interface was visible using a novel blue-green color scheme to highlight contrasting histological features. 14 Similar imaging results were noted after corticectomy and dissection, simulating intraoperative conditions during brain tumor surgery. Moreover, this study showed a near-perfect correlation (k = 0.98) between SRS and H & E microscopy for detection of glioma infiltration based on neuropathologist assessment. These results indicate that in vivo SRS microscopy can approach the gold standard in histopathology.
Quantitative SRS microscopy was recently developed based on the alterations in tissue cellularity, axonal density, and protein/lipid ratio in tumor-infiltrated tissues. 21 A classifier system based on these parameters was able to detect tumor infiltration with 97.5% sensitivity and 98.5% specificity. Quantitative SRS microscopy detected tumor infiltration in grossly normal brain, providing evidence that this technique could improve tumor detection during brain tumor surgery. A comparison of the accuracy of tumor detection using Raman spectroscopy and CRS microscopy can be found in Table 3 .
One barrier to translation of SRS microscopy into the clinical setting is determining how microscopic scale data, collected with small fields of view (400 × 400 μm) could be applied within the context of a large resection cavity. A previous clinical trial using intraoperative confocal microscopy for detection of low-grade glioma used a similarly sized field of view (475 × 475 μm). 45 Using an iterative image-resect-image technique throughout tumor removal, additional operative time was 10 minutes for image ac-quisition and was not obstructive to surgical workflow. Based on previous advances in Raman-based technologies and our own preliminary work, our group has developed a clinical CRS microscopy system that is currently under evaluation for intraoperative use. We believe that Ramanbased technologies are nearing a critical point of clinical translation where large-scale clinical trials can be planned to confirm promising preclinical results.
Conclusions
Raman spectroscopy and CRS microscopy are promising novel methods in brain tumor surgery that have been developed to improve the accuracy of tumor detection and better characterize tumor invasion and molecular features. Real-time in vivo Raman spectroscopy is a developing tool in brain tumor surgery with potential for integration into the neurosurgical workflow. CRS microscopy is a rapid, label-free imaging method capable of identifying tumor and delineating the brain/tumor interface. CRS microscopy has near-perfect agreement with standard H & E microscopy, and tumor infiltration can be quantified with precision. It is our hope that leaving residual tumor will become an operative strategy used only to reduce postoperative neurological morbidity, but never as a result of inadequate tumor identification. Translational research in Raman-based technology suggests that these methods will play an important role in improving the accuracy of brain tumor surgery. 
